Difference between revisions of "Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5 (Q9885)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2019, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: title (P93): Characterizing the Wnt pathway in advanced prostate cancer: when why and how., #quickstatements; #temporary_batch_1590010982689) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Eur. Urol. | ||
| Property / Published In Name String: Eur. Urol. / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Characterizing the Wnt pathway in advanced prostate cancer: when why and how. (English) | ||
| Property / title: Characterizing the Wnt pathway in advanced prostate cancer: when why and how. (English) / rank | |||
| + | Normal rank | ||
Latest revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pal SK
0 references
Swami U
0 references
Agarwal N
0 references
2019
0 references
Eur. Urol.
0 references
Characterizing the Wnt pathway in advanced prostate cancer: when why and how. (English)
0 references
